About MedicaPharma
MedicaPharma distributes high-quality active pharmaceutical ingredients (APIs) to hospitals, commercial (compounding) pharmacies, research institutes, and universities worldwide.
Network of over +400 GMP API producers
Let us handle your sourcing / supply activities. Highly experienced in sourcing specialty raw pharmaceutical ingredients from niche GMP manufacturers around the world.
Why Choose MedicaPharma
Niche API specialist - Pro-active supply partner - High service level - Global network - Logistics according to GDP regulations
Product Description
Mechanism of Action
NORGESTIMATE exhibits a complex and multipathway biochemical activity pattern that may involve modulation of enzymeregulated catalytic cascades, receptormediated intracellular signalling, mitochondrial bioenergetics, redoxstate homeostasis, membranepotential stabilisation, and transcriptionfactor regulatory networks. Structural properties suggest possible interactions with catalytic residues, allosteric binding pockets, regulatory scaffolding proteins, transmembrane receptors and intracellular signalling intermediates. These mechanisms allow NORGESTIMATE to influence phosphorylationdephosphorylation cycles, secondmessenger systems (Ca²⁺, cAMP, IP, DAG), ROS buffering dynamics, ATP synthesis efficiency and the structural organisation of cytoskeletal components.
Depending on concentration and biological context, NORGESTIMATE may shift metabolic routing, alter calcium flux, affect vesicular transport, reshape transcriptomic output and modify mitochondrial respiratorychain performance, contributing to its broad experimental applicability.
Benefits and Advantages
This compound is frequently used in advanced biochemical, pharmacological and mechanistic research areas, including:
- Receptorligand interaction profiling and affinitymapping studies
- Enzymekinetic characterisation and catalyticpathway modelling
- Mitochondrialfunction assays, ATPflux analysis and oxidativestress modelling
- Transcriptomics, proteomics, metabolomics and phosphoproteomics investigations
- Cytoskeletaldynamics studies involving actin/tubulin regulation and membranemechanics research
- Apoptosis, autophagy, ferroptosis and necroptosis pathway explorations
- Structureactivity relationship (SAR) development and molecularperformance optimisation
- Pharmacodynamic threshold modelling and doseresponse curve definition
Side Effects and Risks
Laboratoryobserved or theoretically predicted risks include:
- Redox imbalance, ROS accumulation and oxidativestress sensitisation
- Mitochondrial overload or suppression of respiratorychain complexes
- Disruption of ionchannel homeostasis (Na⁺/K⁺/Ca²⁺)
- Unintended receptor crossactivation or inhibition
- membrane-integrity compromise and cytoskeletal destabilisation
- Dosedependent cytotoxicity, apoptosis or excessive autophagy
- Transcriptional pathway destabilisation or inflammatory activation (NF-κB, JNK, MAPK)
Prolonged exposure or excessive dosing may trigger metabolic collapse, transcriptional rewiring or epigenetic instability. Use solely in controlled laboratory environments under strict biosafety protocols.
Only GMP materials will be supplied, logistics all according to GDP.
Datasheet
| Molecular Formula | C23H31NO3 |
|---|---|
| Molecular Weight | 369.5 g/mol |
| CAS Number | 35189-28-7 |
| Storage Condition | Store at 25 °C (77 °F); excursions permitted to 15- 30 °C (59 – 86 °F). |
| Solubility | 5.31e-03 g/L |
| Purity | Purity information is available upon request (COA). |
| Synonym | NORGESTIMATE; 35189-28-7; Dexnorgestrel acetime; Norgestimato; Norgestimatum |
| IUPAC/Chemical Name | [(3E,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate |
| InChl Key | KIQQMECNKUGGKA-NMYWJIRASA-N |
| InChl Code | InChI=1S/C23H31NO3/c1-4-22-12-10-19-18-9-7-17(24-26)14-16(18)6-8-20(19)21(22)11-13-23(22,5-2)27-15(3)25/h2,14,18-21,26H,4,6-13H2,1,3H3/b24-17+/t18-,19+,20+,21-,22-,23-/m0/s1 |
| References |
3D Conformer.
(Click, turn or enlarge)
Download our GMP API Product List.
MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.
